Amazon continues to expand its reach in the healthcare industry with the launch of a new monthly subscription plan for U.S. Prime members. The $5 plan, named RxPass, offers a wide range of generic drugs and their doorstep delivery, making it easier for Prime members to access and manage their medication. With more than 50 medications addressing over 80 chronic conditions such as high blood pressure, anxiety, diabetes, and male pattern baldness, RxPass aims to provide affordable and convenient access to medication for Prime members.
However, customers enrolled in Medicare, Medicaid or any other government healthcare program will not be able to enroll in Amazon Pharmacy's RxPass service. The average Prime member would save about $100 per year with RxPass, according to John Love, Vice President of Amazon Pharmacy. Amazon Prime members in most U.S. states can sign up for the program starting Tuesday.
It's worth noting that the $5 charge is in addition to the Prime membership fee, which costs $139 per year in the United States. This service aligns with Amazon's ongoing focus on its healthcare portfolio, which over the recent years has included telehealth, drug delivery, fitness trackers, and cancer research.
The launch of RxPass poses a significant threat to traditional drugstore retailers such as CVS Health Corp and Walgreens Boots Alliance Inc, as it allows Amazon to offer a wider range of products and services to customers. With the integration of PillPack, an online pharmacy, and the launch of RxPass, Amazon is now able to offer a comprehensive prescription delivery and price-comparison service.
"We believe a lot of Americans, particularly those that suffer from a chronic illness, are going to benefit from just Amazon's participation in pharmacy, the ability to get high-quality experience delivered to your door at low cost," says Love.
In summary, Amazon's RxPass subscription service, at $5 per month, is an affordable and convenient way for Prime members to access and manage their medication. With more than 50 medications addressing over 80 chronic conditions, it offers a wide range of generic drugs and doorstep delivery, However, customers enrolled in Medicare, Medicaid or any other government healthcare program will not be able to enroll. This new service aligns with Amazon's ongoing focus on its healthcare portfolio, and it poses a significant threat to traditional drugstore retailers such as CVS Health Corp and Walgreens Boots Alliance Inc.
Source : Yahoo News
(Reporting by Jeffery Dastin in Palo Alto, California and Chavi Mehta in Bengaluru; Editing by Devika Syamnath)
0 Comments